Neutrophil-to-lymphocyte ratio as a prognostic factor in patients with acute pulmonary embolism on the background of oncological disease

Background. Current risk stratification methods for patients with pulmonary embolism (PE) in the context of malignancy do not account for all factors influencing disease course and prognosis. This underscores the importance of investigating inflammatory markers, particularly the neutrophil-to-lympho...

Full description

Saved in:
Bibliographic Details
Main Authors: V.Y. Tseluyko, N.H. Shylo
Format: Article
Language:English
Published: Zaslavsky O.Yu. 2025-05-01
Series:Медицина неотложных состояний
Subjects:
Online Access:https://emergency.zaslavsky.com.ua/index.php/journal/article/view/1868
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850068433534713856
author V.Y. Tseluyko
N.H. Shylo
author_facet V.Y. Tseluyko
N.H. Shylo
author_sort V.Y. Tseluyko
collection DOAJ
description Background. Current risk stratification methods for patients with pulmonary embolism (PE) in the context of malignancy do not account for all factors influencing disease course and prognosis. This underscores the importance of investigating inflammatory markers, particularly the neutrophil-to-lymphocyte ratio (NLR) as an accessible and informative prognostic tool. Objective: to determine the clinical and prognostic significance of NLR in patients with acute PE and concomitant cancer. Materials and methods. A retrospective analysis of 291 medical records of patients with acute PE treated at Kharkiv City Clinical Hospital 8 from 2018 to 2020 was conducted, including 92 participants with confirmed malignancy. PE diagnosis was verified by computed tomography pulmonary angiography and/or autopsy findings. All patients underwent laboratory and ultrasound examinations, as well as risk assessment for PE and early mortality according to the 2019 ESC guidelines. Data obtained were subjected to statistical analysis. Results. A comparative assessment of clinical, instrumental, and laboratory parameters was performed in patients with PE depending on cancer presence. Participants with malignancy were older (64 vs. 60.4 years), more frequently had a history of venous thrombosis (15.08 vs. 12.68 %), blood transfusions, and central venous catheter use. Elevated NLR (> 3) was more common in elderly patients (p < 0.008), those who had a stroke (p < 0.045), prolonged bed rest (> 3 days; p < 0.065), diabetes mellitus (p < 0.008), obesity (p < 0.089), high early mortality risk (p < 0.0006), PESI class V (p < 0.001), and high-risk sPESI scores (p < 0.0002). In cancer patients, elevated NLR was associated with kidney disease (p < 0.013), extended bed rest (> 3 days), atrial enlargement, increased left ventricular end-systolic diameter, elevated leukocyte count, fibrinogen, and troponin I levels, and inversely correlated with oxygen saturation and ejection fraction. Conclusions. In cancer patients with PE, elevated NLR is associated with more significant oxygen desaturation, cardiac chamber enlargement, increased cardiomyocyte injury markers, and a higher percentage of patients at elevated in-hospital mortality risk based on established criteria.
format Article
id doaj-art-8ee9fd3eefa8469d83efd5368d418b14
institution DOAJ
issn 2224-0586
2307-1230
language English
publishDate 2025-05-01
publisher Zaslavsky O.Yu.
record_format Article
series Медицина неотложных состояний
spelling doaj-art-8ee9fd3eefa8469d83efd5368d418b142025-08-20T02:48:03ZengZaslavsky O.Yu.Медицина неотложных состояний2224-05862307-12302025-05-0121326327010.22141/2224-0586.21.3.2025.18681868Neutrophil-to-lymphocyte ratio as a prognostic factor in patients with acute pulmonary embolism on the background of oncological diseaseV.Y. Tseluyko0https://orcid.org/0000-0003-4105-1915N.H. Shylo1https://orcid.org/0009-0009-6404-2254V.N. Karazin Kharkiv National University, Kharkiv, UkraineV.N. Karazin Kharkiv National University, Kharkiv, UkraineBackground. Current risk stratification methods for patients with pulmonary embolism (PE) in the context of malignancy do not account for all factors influencing disease course and prognosis. This underscores the importance of investigating inflammatory markers, particularly the neutrophil-to-lymphocyte ratio (NLR) as an accessible and informative prognostic tool. Objective: to determine the clinical and prognostic significance of NLR in patients with acute PE and concomitant cancer. Materials and methods. A retrospective analysis of 291 medical records of patients with acute PE treated at Kharkiv City Clinical Hospital 8 from 2018 to 2020 was conducted, including 92 participants with confirmed malignancy. PE diagnosis was verified by computed tomography pulmonary angiography and/or autopsy findings. All patients underwent laboratory and ultrasound examinations, as well as risk assessment for PE and early mortality according to the 2019 ESC guidelines. Data obtained were subjected to statistical analysis. Results. A comparative assessment of clinical, instrumental, and laboratory parameters was performed in patients with PE depending on cancer presence. Participants with malignancy were older (64 vs. 60.4 years), more frequently had a history of venous thrombosis (15.08 vs. 12.68 %), blood transfusions, and central venous catheter use. Elevated NLR (> 3) was more common in elderly patients (p < 0.008), those who had a stroke (p < 0.045), prolonged bed rest (> 3 days; p < 0.065), diabetes mellitus (p < 0.008), obesity (p < 0.089), high early mortality risk (p < 0.0006), PESI class V (p < 0.001), and high-risk sPESI scores (p < 0.0002). In cancer patients, elevated NLR was associated with kidney disease (p < 0.013), extended bed rest (> 3 days), atrial enlargement, increased left ventricular end-systolic diameter, elevated leukocyte count, fibrinogen, and troponin I levels, and inversely correlated with oxygen saturation and ejection fraction. Conclusions. In cancer patients with PE, elevated NLR is associated with more significant oxygen desaturation, cardiac chamber enlargement, increased cardiomyocyte injury markers, and a higher percentage of patients at elevated in-hospital mortality risk based on established criteria.https://emergency.zaslavsky.com.ua/index.php/journal/article/view/1868pulmonary embolismmalignancyneutrophil-to-lymphocyte ratio
spellingShingle V.Y. Tseluyko
N.H. Shylo
Neutrophil-to-lymphocyte ratio as a prognostic factor in patients with acute pulmonary embolism on the background of oncological disease
Медицина неотложных состояний
pulmonary embolism
malignancy
neutrophil-to-lymphocyte ratio
title Neutrophil-to-lymphocyte ratio as a prognostic factor in patients with acute pulmonary embolism on the background of oncological disease
title_full Neutrophil-to-lymphocyte ratio as a prognostic factor in patients with acute pulmonary embolism on the background of oncological disease
title_fullStr Neutrophil-to-lymphocyte ratio as a prognostic factor in patients with acute pulmonary embolism on the background of oncological disease
title_full_unstemmed Neutrophil-to-lymphocyte ratio as a prognostic factor in patients with acute pulmonary embolism on the background of oncological disease
title_short Neutrophil-to-lymphocyte ratio as a prognostic factor in patients with acute pulmonary embolism on the background of oncological disease
title_sort neutrophil to lymphocyte ratio as a prognostic factor in patients with acute pulmonary embolism on the background of oncological disease
topic pulmonary embolism
malignancy
neutrophil-to-lymphocyte ratio
url https://emergency.zaslavsky.com.ua/index.php/journal/article/view/1868
work_keys_str_mv AT vytseluyko neutrophiltolymphocyteratioasaprognosticfactorinpatientswithacutepulmonaryembolismonthebackgroundofoncologicaldisease
AT nhshylo neutrophiltolymphocyteratioasaprognosticfactorinpatientswithacutepulmonaryembolismonthebackgroundofoncologicaldisease